Cephalosporins Should Be the Preferred Oral Antibiotics for Empiric Treatment of Outpatient Acute Pyelonephritis
When treating suspected outpatient pyelonephritis, consider de-escalating from fluoroquinolones or TMP-SMX to a cephalosporin agent if local resistance patterns allow. Remember that while stewardship is key, selecting an appropriate oral agent promptly remains vital to prevent progression to sepsis or AKI. Always confirm local antibiogram data before making this switch.
This article provides an updated recommendation regarding the empiric oral antibiotic choice for managing acute pyelonephritis in the outpatient setting, a common and potentially serious ED presentation. While fluoroquinolones and TMP-SMX have historically been the go-to options per consensus guidelines, this review suggests that cephalosporins should now be considered the preferred first-line agent. The goal remains consistent: achieving clinical cure while rigorously supporting antimicrobial stewardship to prevent complications like sepsis or renal injury. Choosing the right oral regimen is critical for timely management in the ED.